Safety and efficacy of rotavirus vaccine in infants admitting NICU; comparison between RV1 and RV5.

Safety and efficacy of rotavirus vaccine in infants admitting NICU; comparison between RV1 and RV5. - Safety and efficacy of rotavirus vaccine in infants admitting NICU.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016458

Enrollment

Registered

2015-02-06

Start date

2015-02-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infants in NICU

Interventions

RV1 rotavirus vaccine RV5 rotavirus vaccine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Infants in NICU that meet to the requirements for rotavirus vaccine.

Exclusion criteria

Exclusion criteria: Underlying diseases associated with gastrointestinal disease.

Design outcomes

Primary

Measure	Time frame
Spreading of rotavirus vaccine strains in NICU.	—

Countries

Japan

Contacts

Public ContactTetsushi Yoshikawa

Fujita Health University School of Medicine Dept. of Pediatrics

tetsushi@fujita-hu.ac.jp+81-562-93-9251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026